Mark T. Hughes

Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM

B. Bernstein, Y. Drier, L. Sequist, 2017, Clinical Cancer Research.

Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

U. McDermott, M. Garnett, A. Dastur, 2016, Cancer cell.

Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis

M. Salto‐Tellez, S. Barry, B. Thompson, 2021, Nature Communications.

Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy

J. Arribas, C. Costa, H. Harada, 2018, Proceedings of the National Academy of Sciences.

Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target

Katherine Sellers, S. Barry, C. Nourse, 2023, Nature Metabolism.